Skip to main content
Clinical Trials/JPRN-UMIN000047559
JPRN-UMIN000047559
Recruiting
Phase 3

Management of advanced esophageal cancer patients received chemotherapy using early ctDNA dynamics - CHANGE-ES01 study

Division of Biomedical Research and Development, Institute of Biomedical Sciences, Iwate Medical University0 sites60 target enrollmentApril 25, 2022

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Esophageal cancer
Sponsor
Division of Biomedical Research and Development, Institute of Biomedical Sciences, Iwate Medical University
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 25, 2022
End Date
January 31, 2027
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Division of Biomedical Research and Development, Institute of Biomedical Sciences, Iwate Medical University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Synchronous malignancies except for early cancer which will not affect prognosis. 2\) Patients with active infection with fever requiring a systematic therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials